Correlation Between Scpharmaceuticals and Travere Therapeutics
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Travere Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Travere Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Travere Therapeutics, you can compare the effects of market volatilities on Scpharmaceuticals and Travere Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Travere Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Travere Therapeutics.
Diversification Opportunities for Scpharmaceuticals and Travere Therapeutics
-0.72 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Scpharmaceuticals and Travere is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Travere Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Travere Therapeutics and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Travere Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Travere Therapeutics has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Travere Therapeutics go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and Travere Therapeutics
Given the investment horizon of 90 days Scpharmaceuticals is expected to under-perform the Travere Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Scpharmaceuticals is 1.09 times less risky than Travere Therapeutics. The stock trades about -0.03 of its potential returns per unit of risk. The Travere Therapeutics is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 786.00 in Travere Therapeutics on August 29, 2024 and sell it today you would earn a total of 1,084 from holding Travere Therapeutics or generate 137.91% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Scpharmaceuticals vs. Travere Therapeutics
Performance |
| Timeline |
| Scpharmaceuticals |
| Travere Therapeutics |
Scpharmaceuticals and Travere Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and Travere Therapeutics
The main advantage of trading using opposite Scpharmaceuticals and Travere Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Travere Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Travere Therapeutics will offset losses from the drop in Travere Therapeutics' long position.| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
| Travere Therapeutics vs. Cytokinetics | Travere Therapeutics vs. Ventyx Biosciences | Travere Therapeutics vs. Cogent Biosciences | Travere Therapeutics vs. Nuvalent |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |